Scott L Weiss1, Julie C Fitzgerald1, Edward Vincent Faustino2, Marino S Festa3, Ericka L Fink4, Philippe Jouvet5, Jenny L Bush1, Niranjan Kissoon6, John Marshall7, Vinay M Nadkarni1, Neal J Thomas8. 1. Division of Critical Care Medicine, Department of Anesthesia and Critical Care, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 2. Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA. 3. Kids Critical Care Research, Children's Hospital at Westmead, Sydney, Australia. 4. Department of Critical Care Medicine, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. 5. Pediatric Intensive Care Unit and Research Center, Sainte-Justine Hospital, Montreal, Canada. 6. Division of Critical Care, Department of Pediatrics, University of British Columbia, Canada. 7. Departments of Surgery and Critical Care Medicine, St. Michael's Hospital, University of Toronto, Canada. 8. Division of Pediatric Critical Care Medicine, Penn State Hershey Children's Hospital, Penn State University College of Medicine, Hershey, PA, USA.
Abstract
OBJECTIVE: The point prevalence methodology is a valuable epidemiological study design that can optimize patient enrollment, prospectively gather individual-level data, and measure practice variability across a large number of geographic regions and healthcare settings. The objective of this article is to review the design, implementation, and analysis of recent point prevalence studies investigating the global epidemiology of pediatric critical illness. DATA SOURCES: Literature review and primary datasets. STUDY SELECTION: Multicenter, international point prevalence studies performed in PICUs since 2007. DATA EXTRACTION: Study topic, number of sites, number of study days, patients screened, prevalence of disease, use of specified therapies, and outcomes. DATA SYNTHESIS: Since 2007, five-point prevalence studies have been performed on acute lung injury, neurologic disease, thromboprophylaxis, fluid resuscitation, and sepsis in PICUs. These studies were performed in 59-120 sites in 7-28 countries. All studies accounted for seasonal variation in pediatric disease by collecting data over multiple study days. Studies screened up to 6,317 patients and reported data on prevalence and therapeutic variability. Three studies also reported short-term outcomes, a valuable but atypical data element in point prevalence studies. Using these five studies as examples, the advantages and disadvantages and approach to designing, implementing, and analyzing point prevalence studies are reviewed. CONCLUSIONS: Point prevalence studies in pediatric critical care can efficiently provide valuable insight on the global epidemiology of disease and practice patterns for critically ill children.
OBJECTIVE: The point prevalence methodology is a valuable epidemiological study design that can optimize patient enrollment, prospectively gather individual-level data, and measure practice variability across a large number of geographic regions and healthcare settings. The objective of this article is to review the design, implementation, and analysis of recent point prevalence studies investigating the global epidemiology of pediatric critical illness. DATA SOURCES: Literature review and primary datasets. STUDY SELECTION: Multicenter, international point prevalence studies performed in PICUs since 2007. DATA EXTRACTION: Study topic, number of sites, number of study days, patients screened, prevalence of disease, use of specified therapies, and outcomes. DATA SYNTHESIS: Since 2007, five-point prevalence studies have been performed on acute lung injury, neurologic disease, thromboprophylaxis, fluid resuscitation, and sepsis in PICUs. These studies were performed in 59-120 sites in 7-28 countries. All studies accounted for seasonal variation in pediatric disease by collecting data over multiple study days. Studies screened up to 6,317 patients and reported data on prevalence and therapeutic variability. Three studies also reported short-term outcomes, a valuable but atypical data element in point prevalence studies. Using these five studies as examples, the advantages and disadvantages and approach to designing, implementing, and analyzing point prevalence studies are reviewed. CONCLUSIONS: Point prevalence studies in pediatric critical care can efficiently provide valuable insight on the global epidemiology of disease and practice patterns for critically ill children.
Authors: Edward Vincent S Faustino; Sheila Hanson; Philip C Spinella; Marisa Tucci; Sarah H O'Brien; Antonio Rodriguez Nunez; Michael Yung; Edward Truemper; Li Qin; Simon Li; Kimberly Marohn; Adrienne G Randolph Journal: Crit Care Med Date: 2014-05 Impact factor: 7.598
Authors: G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R LeGall; A Morris; R Spragg Journal: Intensive Care Med Date: 1994 Impact factor: 17.440
Authors: Douglas F Willson; J Michael Dean; Christopher Newth; Murray Pollack; K J S Anand; Kathleen Meert; Joseph Carcillo; Jerry Zimmerman; Carol Nicholson Journal: Pediatr Crit Care Med Date: 2006-07 Impact factor: 3.624
Authors: R Scott Watson; Sheri S Crow; Mary E Hartman; Jacques Lacroix; Folafoluwa O Odetola Journal: Pediatr Crit Care Med Date: 2017-03 Impact factor: 3.624
Authors: Fran Balamuth; Scott Weiss; Mark Neuman; Halden Scott; Patrick Brady; Reid Farris; Richard McClead; Katie Hayes; Raina Paul; Matt Hall; Samir Shah; Elizabeth Alpern Journal: Pediatr Crit Care Med Date: 2015-05 Impact factor: 3.624
Authors: Scott L Weiss; Julie C Fitzgerald; John Pappachan; Derek Wheeler; Juan C Jaramillo-Bustamante; Asma Salloo; Sunit C Singhi; Simon Erickson; Jason A Roy; Jenny L Bush; Vinay M Nadkarni; Neal J Thomas Journal: Am J Respir Crit Care Med Date: 2015-05-15 Impact factor: 21.405
Authors: Ericka L Fink; Patrick M Kochanek; Robert C Tasker; John Beca; Michael J Bell; Robert S B Clark; Jamie Hutchison; Monica S Vavilala; Anthony Fabio; Derek C Angus; R Scott Watson Journal: Pediatr Crit Care Med Date: 2017-04 Impact factor: 3.624
Authors: John S Giuliano; Barry P Markovitz; Joe Brierley; Richard Levin; Gary Williams; Lucy Chai See Lum; Tavey Dorofaeff; Pablo Cruces; Jenny L Bush; Luke Keele; Vinay M Nadkarni; Neal J Thomas; Julie C Fitzgerald; Scott L Weiss Journal: Pediatr Crit Care Med Date: 2016-06 Impact factor: 3.624